FTC Chair Lina Khan (Photo by Michael Brochstein/Sipa USA)(Sipa via AP Images)
September 14, 2023 12:28 PM EDTUpdated 02:04 PM
Pharma

FTC is­sues pol­i­cy con­demn­ing the im­prop­er list­ing of patents in FDA's Or­ange Book

Zachary Brennan

Senior Editor

The Fed­er­al Trade Com­mis­sion vot­ed 3-0 on Thurs­day to is­sue a pol­i­cy state­ment to in­crease scruti­ny of im­prop­er list­ing of patents in the FDA’s Or­ange …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Mi­crosoft-backed Enve­da rais­es $130M for drugs in I&I, obe­si­ty and oth­er ar­eas

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times